Zeng Ying Ms. 4

4 · iQIYI, Inc. · Filed May 13, 2026

AI-generated summary of this filing

Updated May 13, 2026

iQIYI (IQ) Interim CFO Zeng Ying Receives Stock Option Awards

What Happened

Zeng Ying, interim Chief Financial Officer of iQIYI, was reported in a Form 4 (filed 2026-05-13) as involved in derivative transactions on 2026-05-11. The filing shows two dispositions to the issuer (cancellations/amendments) of 480,056 and 700,000 option units and two corresponding grants/awards of 480,056 and 700,000 option units — a total of 1,180,056 derivative-share equivalents. No dollar prices are reported (N/A) because these are option/derivative transactions rather than open-market stock trades.

Key Details

Transaction date: 2026-05-11; Form 4 filed: 2026-05-13 (timely within the typical 2-business-day window).
Reported amounts: dispositions of 480,056 and 700,000 derivative units; grants of 480,056 and 700,000 derivative units (total 1,180,056).
Price/Value: N/A on the filing (derivative/option transactions).
Vesting and term notes: new awards vest over four years with 25% vesting on each anniversary starting 05/11/2026 (footnote F1). The amendments may have involved cancellation of original options and grant of new options with extended expiration to 10/18/2030 (footnotes F3 and F5). The filing also references previously vested/cancelled option tranches (footnotes F2 and F4).
Shares/options owned after the transactions: not specified in the excerpted data.
No indication in the filing excerpt of a 10b5-1 plan, tax withholding sale, or that shares were immediately sold for cash.

Context

These are derivative transactions (options/amendments), not open-market purchases or sales of common stock. The filing indicates old option rights were amended/cancelled and replaced by new option awards with a multi-year vesting schedule and extended expiration dates. Such option amendments are administrative/compensation events and do not by themselves indicate open-market buying or selling of the company’s common stock.

Form 4

Period: 2026-05-11

Interim CFO

Transactions

Disposition to Issuer
Option (right to buy)
[F3][F2]
2026-05-11−480,056→ 0 total
Exercise: $0.51Exp: 2027-02-14→ Class A ordinary share (480,056 underlying)
Award
Option (rignt to buy)
[F3][F2]
2026-05-11+480,056→ 480,056 total
Exercise: $0.51Exp: 2030-10-18→ Class A ordinary share (480,056 underlying)
Disposition to Issuer
Option (right to buy)
[F5][F4]
2026-05-11−700,000→ 0 total
Exercise: $0.51Exp: 2028-02-28→ Class A ordinary share (700,000 underlying)
Award
Option (right to buy)
[F5][F4]
2026-05-11+700,000→ 700,000 total
Exercise: $0.51Exp: 2030-10-18→ Class A ordinary share (700,000 underlying)

Holdings

Option (right to buy)
[F1]
Exercise: $0.00Exp: 2036-05-11→ Class A ordinary share (1,050,000 underlying)
1,050,000

Footnotes (5)

[F1]The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.
[F2]The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
[F3]The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.
[F4]The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
[F5]The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

Signature

/s/ Zeng Ying|2026-05-13

1 file